Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist

Women with mutations in the breast cancer susceptibility gene BRCA1 are predisposed to breast and ovarian cancers. Why the BRCA1 protein suppresses tumor development specifically in ovarian hormone–sensitive tissues remains unclear. We demonstrate that mammary glands of nulliparous Brca1/p53-deficient mice accumulate lateral branches and undergo extensive alveologenesis, a phenotype that occurs only during pregnancy in wild-type mice. Progesterone receptors, but not estrogen receptors, are overexpressed in the mutant mammary epithelial cells because of a defect in their degradation by the proteasome pathway. Treatment of Brca1/p53-deficient mice with the progesterone antagonist mifepristone (RU 486) prevented mammary tumorigenesis. These findings reveal a tissue-specific function for the BRCA1 protein and raise the possibility that antiprogesterone treatment may be useful for breast cancerpreventioninindividuals with BRCA1 mutations.

[1]  M. Pike,et al.  Postmenopausal hormone therapy and breast cancer risk: The multiethnic cohort , 2006, International journal of cancer.

[2]  P. Chambon,et al.  Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Crow.  Early American genetics journals , 2005, Nature Reviews Genetics.

[4]  Mark D. Aupperlee,et al.  Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development. , 2005, Endocrinology.

[5]  S. Furuta,et al.  Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Minglin Li,et al.  Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer , 2005, Oncogene.

[7]  B. O’Malley,et al.  A contemporary understanding of progesterone receptor function , 2004, Mechanisms of Ageing and Development.

[8]  A. Ashworth,et al.  Hallmarks of 'BRCAness' in sporadic cancers , 2004, Nature Reviews Cancer.

[9]  K. Offit,et al.  Increased Progesterone Receptor Expression in Benign Epithelium of BRCA1-Related Breast Cancers , 2004, Cancer Research.

[10]  Wen-Hwa Lee,et al.  The DNA double-strand break response pathway: becoming more BRCAish than ever. , 2004, DNA repair.

[11]  E. Rosen,et al.  BRCA1 Inhibits Membrane Estrogen and Growth Factor Receptor Signaling to Cell Proliferation in Breast Cancer , 2004, Molecular and Cellular Biology.

[12]  S. Hilsenbeck,et al.  Somatic Mutation of p53 Leads to Estrogen Receptor α-Positive and -Negative Mouse Mammary Tumors with High Frequency of Metastasis , 2004, Cancer Research.

[13]  F. DeMayo,et al.  Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  V. Beral,et al.  Evidence from randomised trials on the long-term effects of hormone replacement therapy , 2002, The Lancet.

[15]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[16]  W. Lee,et al.  BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Ohta,et al.  The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation* , 2001, The Journal of Biological Chemistry.

[18]  P. L. Chen,et al.  Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. , 2000, Molecular cell.

[19]  James A. Clark,et al.  Induction of Mammary Gland Development in Estrogen Receptor-α Knockout Mice. , 2000, Endocrinology.

[20]  M. Erdos,et al.  BRCA1 inhibition of estrogen receptor signaling in transfected cells. , 1999, Science.

[21]  Thomas Ried,et al.  Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation , 1999, Nature Genetics.

[22]  R. Weinberg,et al.  A paracrine role for the epithelial progesterone receptor in mammary gland development. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Barcellos-Hoff,et al.  Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B. O’Malley,et al.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. , 1995, Genes & development.

[25]  David L. Page,et al.  Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression , 1995, Nature Genetics.

[26]  K. Korach.  Insights from the study of animals lacking functional estrogen receptor. , 1994, Science.

[27]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[28]  F. Bresciani.  DNA Synthesis in Alveolar Cells of the Mammary Gland: Acceleration by Ovarian Hormones , 1964, Science.

[29]  S. Nandi,et al.  Endocrine control of mammarygland development and function in the C3H/ He Crgl mouse. , 1958, Journal of the National Cancer Institute.

[30]  E. Rosen,et al.  The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. , 2006, Molecular endocrinology.

[31]  C. Lange,et al.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[33]  D. Botstein,et al.  References and Notes , 2022 .